Prospective phase II trial of cetuximab plus VMAT-SIB in locally advanced head and neck squamous cell carcinoma. Feasibility and tolerability in elderly and chemotherapy-ineligible patients.
Strahlenther Onkol
; 188(1): 49-55, 2012 Jan.
Article
in En
| MEDLINE
| ID: mdl-22194030
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Otorhinolaryngologic Neoplasms
/
Carcinoma, Squamous Cell
/
Chemoradiotherapy
/
Antibodies, Monoclonal
/
Antineoplastic Agents
Type of study:
Etiology_studies
/
Risk_factors_studies
Limits:
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Strahlenther Onkol
Journal subject:
NEOPLASIAS
/
RADIOTERAPIA
Year:
2012
Document type:
Article
Affiliation country:
Italy
Country of publication:
Germany